age well

Leading the conversation in hormone health and wellness

From media outlets to regional features, RegenCen is recognized as a leader in hormone health, menopause treatments, and regenerative medicine. Our founders are honored to share their expertise and help shape the conversation around vitality, aging, and science-based approaches to living well.

What the FDA’s hormone therapy update means for women: Dr. Gustav Lo explains

For more than 20 years, women were warned away from hormone replacement therapy (HRT) and left to struggle through hot flashes, sleep disruption, fatigue, and mood changes. Now, the FDA has reversed its stance on menopause hormone therapy, acknowledging what the science has shown all along. At RegenCen, we’ve offered personalized, medically guided hormone care from the beginning, long before the FDA finally caught up.

In these media interviews, Dr. Gustav Lo, Founder and Chief Medical Officer of RegenCen, explains what this historic update means for menopause treatment, why outdated fears were misleading, and how bioidentical hormone therapy can restore energy, clarity, sleep, and long-term health protection for women in perimenopause, menopause, and beyond.

Menopause has a new future, and you deserve to be part of it.

Warning Labels Removed from HRT Drugs - Dr. Gustav Lo

How hormone therapies can help women and the FDA update

RegenCen commercial media

Weight loss

Low testosterone, or "Low T"

Unique menopause experience

Weight management

RegenCen magazine publications

RegenCen radio interviews

Innovative approaches to sustainable weight loss (Part one of three)

Innovative approaches to sustainable weight loss (Part two of three)

Innovative approaches to sustainable weight loss (Part three of three)

Menopause relief with Dr. Gustav Lo - The Lucy Ann Lance Show

Anti-aging & longevity with Dr. Gustav Lo - The Lucy Ann Lance Show

Longevity, Hormones, and Healthspan: A Conversation with Dr. Lo

Interested in featuring us?

Contact Brooke Harris at brooke@cslcbeauty.com for all PR requests.